Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.24 USD | 0.00% | +13.78% | +182.51% |
May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
May. 15 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+182.51% | 1.07B | |
+7.77% | 113B | |
+10.92% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.62% | 17.24B | |
+6.69% | 14.29B | |
+35.77% | 12.52B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Arcutis Biotherapeutics Chief Commercial Officer Ken Lock to Step Down; Ayisha Jeter Named Interim CCO